Tick-borne encephalitis vaccine

Tick-Borne Encephalitis Vaccine

File:Tick-borne encephalitis virus.jpg

Tick-borne encephalitis virus, the cause of TBE, which the vaccine protects against

The Tick-Borne Encephalitis (TBE) Vaccine is a vaccine used to protect against Tick-borne encephalitis, a viral infectious disease involving the central nervous system. The disease is transmitted by the bite of infected ticks, found in woodland habitats across Europe and Asia.

Overview

The TBE vaccine is an inactivated vaccine, meaning it contains a virus which has been killed and cannot cause disease. It is administered in three doses over a period of six to twelve months, with booster doses recommended every three to five years for those at risk.

Efficacy and Safety

The TBE vaccine has been shown to be highly effective in preventing tick-borne encephalitis. Studies have shown that the vaccine is approximately 96% effective after the third dose. The vaccine is generally well tolerated, with side effects usually mild and temporary.

Availability

The TBE vaccine is available in many countries across Europe and Asia, where TBE is endemic. In some countries, the vaccine is recommended for all residents and long-term visitors, while in others it is recommended only for those at high risk of exposure, such as forest workers and hikers.

See Also

• Vaccination
• Tick-borne disease
• Encephalitis